Suppr超能文献

人β-淀粉样肽前体在酿酒酵母中的表达与加工:酵母分泌系统中一种新型内肽酶的证据

The expression and processing of human beta-amyloid peptide precursors in Saccharomyces cerevisiae: evidence for a novel endopeptidase in the yeast secretory system.

作者信息

Hines V, Zhang W, Ramakrishna N, Styles J, Mehta P, Kim K S, Innis M, Miller D L

机构信息

Department of Microbial Expression, Chiron Corp., Emeryville, CA 94608.

出版信息

Cell Mol Biol Res. 1994;40(4):273-84.

PMID:7866429
Abstract

In mammalian cells, the transmembrane beta-amyloid peptide precursor (beta-APP) undergoes a complex series of alternative proteolytic processing steps that result in the secretion of varying proportions of its extra-cellular domain (protease nexin II) and beta-amyloid peptide. The protein is also reinternalized and degraded in the endosomal-lysosomal system. The relative efficiencies of these competing processes determine the yield of beta-amyloid peptide. Several proteases have been implicated in this complex processing pathway, although none has been identified to date. The yeast secretory system contains proteases homologous to mammalian pro-hormone convertases and is susceptible to genetic manipulation. We therefore investigated the expression and processing of the beta-amyloid peptide precursors (beta-APP-695 and beta-APP-751) in Saccharomyces cerevisiae transformed with human beta-APP cDNA's. beta-APP (695 or 751) cDNA either with its authentic signal sequence or the yeast-derived prepro-alpha-factor leader, was inserted into a glucose-regulated expression vector and transfected into a protease-deficient yeast strain. In all instances, expression of beta-APP was about 1% of total protein. Protease protection studies indicated that either the natural human signal sequence or the alpha-factor leader sequence targetted beta-APP to the endoplasmic reticulum and inserted it with the amino-terminal domain in the lumen. All of the beta-APP fused to the alpha-factor leader proceeded to the trans-Golgi, where Kex2 endopeptidase removed the leader and released the normal amino-terminus of beta-APP. About one-half of the beta-APP was also cleaved at the "alpha-secretase" site in the middle of the beta-peptide sequence, 12 residues before the membrane-spanning sequence. A fraction of the alpha-secretase-cleaved beta-APP appeared in the culture medium; however, most of it associated with the exterior of the cells. The carboxyl-terminal fragments formed by cleavage at the alpha-secretase site accumulated in the membranes. Other proteolytic processes generated membrane-associated carboxyl-terminal fragments that also resembled those found in mammalian cells. These results indicate that the secretory system of S. cerevisiae possesses proteases with specificities similar to the mammalian enzymes that process beta-APP.

摘要

在哺乳动物细胞中,跨膜β-淀粉样肽前体(β-APP)经历一系列复杂的选择性蛋白水解加工步骤,这些步骤导致其细胞外结构域(蛋白酶nexin II)和β-淀粉样肽以不同比例分泌。该蛋白也会被内化并在内体-溶酶体系统中降解。这些相互竞争过程的相对效率决定了β-淀粉样肽的产量。虽然迄今为止尚未鉴定出参与这一复杂加工途径的蛋白酶,但已有几种蛋白酶与之相关。酵母分泌系统含有与哺乳动物激素原转化酶同源的蛋白酶,并且易于进行基因操作。因此,我们研究了用人β-APP cDNA转化的酿酒酵母中β-淀粉样肽前体(β-APP-695和β-APP-751)的表达和加工情况。带有其天然信号序列或酵母来源的前原α-因子前导序列的β-APP(695或751)cDNA被插入到一个葡萄糖调节表达载体中,并转染到一个蛋白酶缺陷型酵母菌株中。在所有情况下,β-APP的表达量约占总蛋白的1%。蛋白酶保护研究表明,无论是天然的人类信号序列还是α-因子前导序列,都将β-APP靶向内质网,并将其氨基末端结构域插入内质网腔中。所有与α-因子前导序列融合的β-APP都进入反式高尔基体,在那里Kex2内肽酶切除前导序列并释放β-APP的正常氨基末端。约一半的β-APP也在β-肽序列中间的“α-分泌酶”位点被切割,该位点位于跨膜序列之前12个残基处。一部分经α-分泌酶切割的β-APP出现在培养基中;然而,大部分与细胞外表面相关。在α-分泌酶位点切割形成的羧基末端片段积累在膜中。其他蛋白水解过程产生的膜相关羧基末端片段也与在哺乳动物细胞中发现的片段相似。这些结果表明,酿酒酵母的分泌系统拥有与加工β-APP的哺乳动物酶具有相似特异性的蛋白酶。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验